Smoking, blood pressure and cardiovascular risk

Journal of Hypertension

Volumn 20, Issue 9, 2002, Pages 1699-1701

  Hausberg, Martin ^a   Kosch, Markus ^a   Barenbrock, Michael ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADRENERGIC SYSTEM; ADULT; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NOTE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0036734345     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200209000-00006     Document Type: Note

References (28)

1. Smoking as a modifier of the systolic blood pressure induced risk of cardiovascular events and mortality - A population-based prospective study of middle-aged men
2. Established risk factors and coronary artery disease: The Framingham Study
3. Predictors of cardiovascular morbidity in treated hypertension: Results from the primary preventive trial in Goteborg, Sweden
4. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990
5. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
6. Underestimation of the true benefits of antihypertensive treatment: An assessment of some important sources of error
7. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Goteborg, Sweden
8. Multiple risk intervention trial in high risk hypertensive men: Comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up
9. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
10. Multiple risk factor interventions for primary prevention of coronary heart disease
11. Coronary artery disease: The role of lipids, hypertension and smoking
12. Coronary heart disease incidence in northern and southern European populations: A reanalysis of the seven countries study for a European coronary risk chart
13. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
14. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis
15. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
16. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts
17. Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: Results from eight nations of the Seven Countries Study, 25-year follow-up
18. Interactive effect of heart rate and muscle sympathetic nerve activity on blood pressure
19. Cigarette smoking increases sympathetic outflow in humans
20. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage
21. Adverse consequences of high sympathetic nervous activity in the failing human heart
22. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease
23. Relation of hemodynamics and risk factors to ventricular-vascular interactions in the elderly: The Cardiovascular Health Study
24. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
25. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules
26. Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects
27. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients
28. Prognostic significance of endothelial dysfunction in hypertensive patients